98%
921
2 minutes
20
Transgender women (TW) face one of the highest HIV burdens worldwide. In Malaysia, 12.4% of TW are HIV infected, ∼30-fold higher than in the Malaysian adult population. Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy, however, little is known about TW's willingness to use PrEP or their preferences for receiving PrEP. This study examined the correlates of Malaysian TW's willingness to use PrEP and their attitudes and preferences related to delivery of PrEP and PrEP-related care. Between June and August 2017, 361 TW in Malaysia completed an online survey about their knowledge of and willingness to use PrEP for HIV prevention. Only 20.2% of participants had ever previously heard of PrEP and none were currently taking PrEP. The majority (82.5%) expressed high willingness to take PrEP and most participants met the World Health Organization (WHO) indication for PrEP (82.3%). In the multivariate model, lifetime hormone use, prior postexposure prophylaxis use, and having completed a high school education were associated with higher willingness to use PrEP, while injection drug use, older age, and Chinese ethnicity were associated with lower PrEP willingness. TW in Malaysia are highly willing to use PrEP for HIV prevention. Differences in willingness to use PrEP identified by education, ethnicity, substance abuse, and age suggest different strategies may be needed to scale-up PrEP for this diverse community of TW.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906238 | PMC |
http://dx.doi.org/10.1089/trgh.2020.0003 | DOI Listing |
Front Public Health
September 2025
School of Public Health, University of Rwanda, Kigali, Rwanda.
Background: Female sex workers (FSWs) in sub-Saharan Africa bear a disproportionate burden of HIV acquisition. While pre-exposure prophylaxis (PrEP) is increasingly accessible in the region, limited data exist on FSWs awareness of and willingness to use PrEP. This study aimed to assess PrEP awareness and willingness to use it, along with associated factors, among FSWs in Kigali, Rwanda.
View Article and Find Full Text PDFPLoS One
September 2025
Departments of Epidemiology and Global Health, University of Washington, School of Public Health, Seattle, Washington, United States of America.
Background: Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention may improve adherence for those with concerns with daily pills. Limited data exist on LAI-PrEP acceptability among Black women in the U.S.
View Article and Find Full Text PDFAIDS Res Ther
August 2025
The Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Background: Long-acting injectable (LAI)-PrEP provides better protection against HIV compared to oral PrEP, which requires taking a daily pill. Our study aimed to assess knowledge about oral and LAI-PrEP and identify factors associated with willingness to use LAI-PrEP among key populations (KPs) in Uganda.
Methods: We conducted a cross-sectional study at the Most at Risk Populations Initiative (MARPI) clinic between November and December 2021.
Phys Occup Ther Pediatr
August 2025
Physical Therapy Department, Graduate Program of Rehabilitation Science, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Aims: To investigate the feasibility and preliminary effects of a modified sports intervention (Sports Stars) combined with a contextual-focused approach (Pathways and Resources for Engagement in Participation- PREP).
Methods: This is a feasibility randomized clinical trial (RCT), registered under RBR-4m3b4b6 and U1111-1256-4998. Eighteen children with cerebral palsy (CP) were allocated to either the Sports Stars Brazil + PREP group ( = 9) or the Sports Stars Brazil group ( = 9).
Porto Biomed J
August 2025
Department of Public Health, University of Calabar, Calabar, Nigeria.
Background: Young people are disproportionately affected by human immunodeficiency virus (HIV) despite recent improvements in biomedical prevention strategies. Pre-exposure prophylaxis (PrEP) is an innovative prevention method that has shown significant promise in the fight against HIV. However, there is limited understanding of young people's knowledge and use of PrEP.
View Article and Find Full Text PDF